Multiple mechanisms for desensitization of A2a adenosine receptor- mediated cAMP elevation in rat pheochromocytoma PC12 cells

Y Chern, HL Lai, JC Fong and Y Liang

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.

To understand the regulation of A2a adenosine receptor (A2a-R) response, we examined the molecular mechanisms underlying the desensitization of A2a response in rat pheochromocytoma PC12 cells, which possess an A2a-R identical with the A2a receptor we recently cloned from rat brain. Prolonged exposure of PC12 cells to adenosine agonists significantly inhibited the response of the cells to subsequent stimulation with an A2a-selective adenosine agonist (CGS21680). No significant change in the number of binding sites and affinity for CGS21680 was observed in desensitized cells, nor did we find any significant change in the transcript level of A2a-R in cells pretreated with adenosine agonists. However, the basal adenylyl cyclase activity and the cyclase activities stimulated by adenosine agonists, by GTP gamma S, and by forskolin were reduced in desensitized cells. Prolonged exposure of PC12 cells to dibutyryl-cAMP did not significantly change either the basal or the adenosine agonist-evoked adenylyl cyclase activity. Therefore, elevation of cellular cAMP content is by itself not sufficient to produce the observed reductions of adenylyl cyclase activity with A2a desensitization. Inhibition of adenylyl cyclase activity in desensitized cells occurred after short- term (30 min) incubation with CGS21680 and could be blocked by the adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine. Gs alpha protein levels did not significantly change after a 30-min exposure to CGS21680. In contrast, long-term exposure (12-20 hr) of PC12 cells to adenosine agonists resulted in a slight further reduction of adenylyl cyclase activity and a consistent decline in the Gs alpha protein level. In addition, long-term incubation with adenosine agonists or with forskolin-enhanced phosphodiesterase (PDE) activity in the cytosolic and membrane fractions by 57 +/- 9% and 53 +/- 18%, respectively. Hydrolysis of cAMP was significantly faster in agonist- desensitized cells than in control cells. PDE might therefore play an important role in desensitization of the A2a response in PC12 cells. Polymerase chain reaction-based analysis of the mRNA for A2a-R and A2b- R indicated that both A2a-R and A2b-R were present in PC12 cells; the A2b response was also diminished in A2a-desensitized cells. Our data suggest that inhibition of adenylyl cyclase after short-term agonist treatment, down-regulation of Gs alpha protein level after long-term agonist treatment, and activation of PDE after long-term agonist treatment account for desensitization of the A2a-mediated response in PC12 cells.

Volume 44, Issue 5, pp. 950-958, 11/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				P.-A. Vidi, B. R. Chemel, C.-D. Hu, and V. J. Watts Ligand-Dependent Oligomerization of Dopamine D2 and Adenosine A2A Receptors in Living Neuronal Cells Mol. Pharmacol., September 1, 2008; 74(3): 544 - 551. [Abstract] [Full Text] [PDF]

				C.-N. Sun, H.-C. Cheng, J.-l. Chou, S.-Y. Lee, Y.-W. Lin, H.-L. Lai, H.-M. Chen, and Y. Chern Rescue of p53 Blockage by the A2A Adenosine Receptor via a Novel Interacting Protein, Translin-Associated Protein X Mol. Pharmacol., August 1, 2006; 70(2): 454 - 466. [Abstract] [Full Text] [PDF]

				N. D. Khoa, M. Postow, J. Danielsson, and B. N. Cronstein Tumor Necrosis Factor-{alpha} Prevents Desensitization of G{alpha}s-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane Mol. Pharmacol., April 1, 2006; 69(4): 1311 - 1319. [Abstract] [Full Text] [PDF]

				M.-C. Chiang, Y.-C. Lee, C.-L. Huang, and Y. Chern cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues J. Biol. Chem., April 8, 2005; 280(14): 14331 - 14340. [Abstract] [Full Text] [PDF]

				J.-l. Chou, C.-L. Huang, H.-L. Lai, A. C. Hung, C.-L. Chien, Y.-Y. Kao, and Y. Chern Regulation of Type VI Adenylyl Cyclase by Snapin, a SNAP25-binding Protein J. Biol. Chem., October 29, 2004; 279(44): 46271 - 46279. [Abstract] [Full Text] [PDF]

				Y.-Y. Kao, H.-L. Lai, M.-J. Hwang, and Y. Chern An Important Functional Role of the N Terminus Domain of Type VI Adenylyl Cyclase in G{alpha}i-mediated Inhibition J. Biol. Chem., August 13, 2004; 279(33): 34440 - 34448. [Abstract] [Full Text] [PDF]

				J. G. Baker, I. P. Hall, and S. J. Hill Temporal Characteristics of cAMP Response Element-Mediated Gene Transcription: Requirement for Sustained cAMP Production Mol. Pharmacol., April 1, 2004; 65(4): 986 - 998. [Abstract] [Full Text]

				H.-C. Cheng, H.-M. Shih, and Y. Chern Essential Role of cAMP-response Element-binding Protein Activation by A2A Adenosine Receptors in Rescuing the Nerve Growth Factor-induced Neurite Outgrowth Impaired by Blockage of the MAPK Cascade J. Biol. Chem., September 6, 2002; 277(37): 33930 - 33942. [Abstract] [Full Text] [PDF]

				T.-H. Lin, H.-L. Lai, Y.-Y. Kao, C.-N. Sun, M.-J. Hwang, and Y. Chern Protein Kinase C Inhibits Type VI Adenylyl Cyclase by Phosphorylating the Regulatory N Domain and Two Catalytic C1 and C2 Domains J. Biol. Chem., May 3, 2002; 277(18): 15721 - 15728. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				S. V. Sitaraman, M. Si-Tahar, D. Merlin, G. R. Strohmeier, and J. L. Madara Polarity of A2b adenosine receptor expression determines characteristics of receptor desensitization Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1230 - C1236. [Abstract] [Full Text] [PDF]

				C. Florio, F. Frausin, R. Vertua, and R. M. Gaion Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824. [Abstract] [Full Text]

				J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens 5-(N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1877 - H1883. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. E. Zvartau Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use Pharmacol. Rev., March 1, 1999; 51(1): 83 - 133. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]

				H.-L. Lai, T.-H. Yang, R. O. Messing, Y.-H. Ching, S.-C. Lin, and Y. Chern Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response J. Biol. Chem., February 21, 1997; 272(8): 4970 - 4977. [Abstract] [Full Text] [PDF]

				G.-C. Wu, H.-L. Lai, Y.-W. Lin, Y.-T. Chu, and Y. Chern N-Glycosylation and Residues Asn805 and Asn890 Are Involved in the Functional Properties of Type VI Adenylyl Cyclase J. Biol. Chem., September 14, 2001; 276(38): 35450 - 35457. [Abstract] [Full Text] [PDF]